203 related articles for article (PubMed ID: 24197392)
1. Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma?
Kawaguchi S; Sun T; Lin PP; Deavers M; Harun N; Lewis VO
Clin Orthop Relat Res; 2014 Mar; 472(3):983-9. PubMed ID: 24197392
[TBL] [Abstract][Full Text] [Related]
2. Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study.
Hompland I; Ferrari S; Bielack S; Palmerini E; Hall KS; Picci P; Hecker-Nolting S; Donati DM; Blattmann C; Bjerkehagen B; Staals E; Kager L; Gambarotti M; Kühne T; Eriksson M; Ferraresi V; Kevric M; Biagini R; Baumhoer D; Brosjø O; Comandone A; Schwarz R; Bertulli R; Kessler T; Hansson L; Apice G; Heydrich BN; Setola E; Flörcken A; Ruggieri P; Krasniqi F; Hofmann-Wackersreuther G; Casali P; Reichardt P; Smeland S
Eur J Cancer; 2021 Jul; 151():150-158. PubMed ID: 33990016
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy is associated with fewer recurrences in mesenchymal chondrosarcoma.
Kawaguchi S; Weiss I; Lin PP; Huh WW; Lewis VO
Clin Orthop Relat Res; 2014 Mar; 472(3):856-64. PubMed ID: 23709273
[TBL] [Abstract][Full Text] [Related]
4. Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes.
Dickey ID; Rose PS; Fuchs B; Wold LE; Okuno SH; Sim FH; Scully SP
J Bone Joint Surg Am; 2004 Nov; 86(11):2412-8. PubMed ID: 15523011
[TBL] [Abstract][Full Text] [Related]
5. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
Fan Z; Patel S; Lewis VO; Guadagnolo BA; Lin PP
Clin Orthop Relat Res; 2015 Nov; 473(11):3604-11. PubMed ID: 26197952
[TBL] [Abstract][Full Text] [Related]
6. High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas.
Yalcin B; Pamir A; Buyukcelik A; Utkan G; Akbulut H; Demirkazik A; Icli F
Exp Oncol; 2004 Dec; 26(4):320-5. PubMed ID: 15627067
[TBL] [Abstract][Full Text] [Related]
7. Does Resection of the Primary Tumor Improve Survival in Patients With Metastatic Chondrosarcoma?
Song K; Song J; Chen F; Lin K; Ma X; Jiang J
Clin Orthop Relat Res; 2019 Mar; 477(3):573-583. PubMed ID: 30762691
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy and P-glycoprotein expression in chondrosarcoma.
Terek RM; Schwartz GK; Devaney K; Glantz L; Mak S; Healey JH; Albino AP
J Orthop Res; 1998 Sep; 16(5):585-90. PubMed ID: 9820282
[TBL] [Abstract][Full Text] [Related]
9. Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database Analysis.
Cranmer LD; Chau B; Mantilla JG; Loggers ET; Pollack SM; Kim TS; Kim EY; Kane GM; Thompson MJ; Harwood JL; Wagner MJ
Clin Orthop Relat Res; 2022 Apr; 480(4):748-758. PubMed ID: 34648466
[TBL] [Abstract][Full Text] [Related]
10. Pelvic chondrosarcomas: surgical treatment options.
Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
[TBL] [Abstract][Full Text] [Related]
11. What Factors Are Associated with Treatment Outcomes of Japanese Patients with Clear Cell Chondrosarcoma?
Nakayama R; Hayakawa K; Kobayashi E; Endo M; Asano N; Yonemoto T; Kawashima H; Hamada K; Watanabe I; Futani H; Goto T; Nishida Y; Ozaki T
Clin Orthop Relat Res; 2020 Nov; 478(11):2537-2547. PubMed ID: 32297725
[TBL] [Abstract][Full Text] [Related]
12. High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patients.
Lee SH; Chang MH; Baek KK; Han B; Lim T; Lee J; Park JO
Oncology; 2011; 80(3-4):257-61. PubMed ID: 21734417
[TBL] [Abstract][Full Text] [Related]
13. Chondrosarcoma of bone: an assessment of outcome.
Lee FY; Mankin HJ; Fondren G; Gebhardt MC; Springfield DS; Rosenberg AE; Jennings LC
J Bone Joint Surg Am; 1999 Mar; 81(3):326-38. PubMed ID: 10199270
[TBL] [Abstract][Full Text] [Related]
14. Dedifferentiated chondrosarcomas arising in preexisting osteochondromas.
Staals EL; Bacchini P; Mercuri M; Bertoni F
J Bone Joint Surg Am; 2007 May; 89(5):987-93. PubMed ID: 17473135
[TBL] [Abstract][Full Text] [Related]
15. Developing an Evidence-based Followup Schedule for Bone Sarcomas Based on Local Recurrence and Metastatic Progression.
Cipriano C; Griffin AM; Ferguson PC; Wunder JS
Clin Orthop Relat Res; 2017 Mar; 475(3):830-838. PubMed ID: 27339121
[TBL] [Abstract][Full Text] [Related]
16. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
Wan L; Tu C; Li S; Li Z
Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
[TBL] [Abstract][Full Text] [Related]
17. Primary Tumor Resection Prolongs Survival in Spinal Chondrosarcoma Patients With Distant Metastasis.
Song K; Lin K; Kang H; Dong Y; Guan H; Li F
Spine (Phila Pa 1976); 2020 Dec; 45(24):E1661-E1668. PubMed ID: 32925686
[TBL] [Abstract][Full Text] [Related]
18. Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.
Dierselhuis EF; Goulding KA; Stevens M; Jutte PC
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010778. PubMed ID: 30845364
[TBL] [Abstract][Full Text] [Related]
19. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
Schneiderman BA; Kliethermes SA; Nystrom LM
Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
[TBL] [Abstract][Full Text] [Related]
20. Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group.
Grimer RJ; Gosheger G; Taminiau A; Biau D; Matejovsky Z; Kollender Y; San-Julian M; Gherlinzoni F; Ferrari C
Eur J Cancer; 2007 Sep; 43(14):2060-5. PubMed ID: 17720491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]